Key facts
- Health Secretary Robert F. Kennedy Jr. is overhauling the U.S. Preventive Services Task Force.
- The goal is to expand coverage for preventive care, including Alzheimer's and kidney disease testing.
- Lobbying efforts are underway by test manufacturers and patient advocacy groups.
- Concerns exist that the changes could lead to increased insurance premiums and a move away from evidence-based medicine.
- Kennedy previously faced legal challenges after overhauling an immunization advisory committee.
Health Secretary Robert F. Kennedy Jr. is initiating a significant overhaul of the U.S. Preventive Services Task Force, signaling a push to expand the range of preventive health screenings covered by insurers. This initiative, particularly Kennedy's focus on mandating coverage for Alzheimer's disease tests, has drawn attention from various industry stakeholders, including test manufacturers and patient advocacy groups who are lobbying for broader recommendations for conditions like kidney and colon cancer.
The American Association of Kidney Patients, represented by Paul Conway, advocates for universal kidney disease screening, arguing it would catch early signs of a costly and deadly illness. However, the task force had previously rejected such expanded screening due to insufficient evidence. Similarly, companies like Guardant Health are pushing for their non-invasive colorectal cancer tests to be recommended as alternatives to colonoscopies.
Kennedy's approach has raised concerns among some medical professionals and patient groups. Aaron Carroll, president and CEO of AcademyHealth, expressed worries that the task force might deviate from evidence-based practices, potentially leading to coverage of services that are not scientifically validated or could even cause harm. Former task force members have also voiced apprehension that Kennedy might prioritize financial interests of individuals in his circle over public health.
This restructuring follows Kennedy's previous actions, such as firing leaders of the task force and canceling most of its meetings. His prior overhaul of the Advisory Committee on Immunization Practices, which led to legal challenges and a temporary block on its guidance, serves as a point of reference for these concerns. The Department of Health and Human Services (HHS) has stated that the changes are not driven by fringe science or political ideology but aim to make the task force less conservative and more responsive to the need for preventive care investments.
Health insurers, represented by AHIP, have stated it is too early to assess the cost impact of potential changes but emphasize the value of the task force's historical evidence-based framework. The administration has indicated that health economists may be added to the task force to better evaluate cost-effectiveness.